Our present study thus expands our understanding of the contribution of miR-125a and miR-125b to AML by demonstrating their prognostic significance as part of immunity-related ceRNA networks that include HCP5 and MEG3 as direct upstream regulators and IL6R and SEMA4C as target genes. This evidence concerns the gene MEG3 and acute myeloid leukemia.